{
 "PrintNo":"S3350","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-01-30T16:51:21.38071Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2023-01-30","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1520,"Name":"Nathalia Fernandez","Short":"FERNANDEZ"}],
 "Title":"Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry",
 "Summary":"Requires practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3343-a, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to requiring practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry",
 "PreviousVersions":["S4374-2017","S4482-2019","S6045-2021"]
}